FDA advisory committee recommends Novavax vaccine for use in adults

FDA advisory committee recommends Novavax vaccine for use in adults

The FDA’s vaccine advisory committee voted in favor of Novavax’s (NVAX) COVID-19 vaccine for use in adults, paving the way for the company to get its first product authorized in the U.S.

But the day-long meeting raised a number of concerns presented by Novavax’s late entry to the vaccine field.

Before any data was even presented, questions were raised by committee members about the need to authorize yet another COVID-19 vaccine, as demand has waned in the U.S., and about the manufacturing…


Source link

About search

Check Also

Kenny Smith hasn't heard from Charles Barkley about retiring from broadcasting: 'We'll see' – Yahoo Sports

European Stocks Drop With US Tech Rally Faltering: Markets Wrap – Yahoo Finance

[unable to retrieve full-text content]European Stocks Drop With US Tech Rally Faltering: Markets Wrap  Yahoo Finance …

Leave a Reply

Your email address will not be published. Required fields are marked *